Belinda Morey explores how GLP-1 medications, long-acting implants, artificial intelligence, virtual reality, and telehealth are reshaping addiction treatment in 2026. By targeting the biology of cravings and increasing consistency and accessibility, these innovations are offering new hope for sustainable recovery — while reinforcing that medication and technology work best when paired with therapy, support, and daily commitment.

John Makohen outlines the early warning signs of alcohol use disorder and emphasizes the critical role substance use counselors play in early identification and intervention.

Rannon Arch reflects on listening sessions with patients who consistently express a desire for belonging — not just symptom reduction.